Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of paricalcitol vs alfacalcidol in secondary hyperparathyroidism in hemodialysis
2007-006645-41Phase 4Active
- Sponsor
- OLVG
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of paricalcitol in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by OLVG. Primary endpoint: Average parathyroid hormone (PTH) level. Started May 2008; status: active.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2007-006645-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006645-41.